Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome
Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2017-01-01
|
| Colección: | Journal of Market Access & Health Policy |
| Materias: | |
| Acceso en línea: | http://dx.doi.org/10.1080/20016689.2017.1318691 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|